Saturday, April 24, 2:00 pm
- Sunday, April 25, Noon
CHAIRS: James K. Kirklin, MD and
Mandeep R. Mehra, MD
This educational activity will offer 10
hours of intensive teaching activity
focusing on core competencies of
Advanced Heart Failure, Mechanical
Circulatory Support, Pulmonary
Hypertension and Cardiac Transplan-
tation. Registration for this Masters
Academy course is limited to the first
150 individuals. You may register via
the Official ISHLT Registration Form.
Registration for the ISHLT Annual
Meeting is NOT required in order to
register for this course.
Saturday, April 24, 2010
1:50 pm
Scientific Program
Opening Remarks
2:00 pm
SESSION 1:
Advanced Heart Failure and
High Risk Surgery
This session will cover the following
topics via lectures and panel discussion:
Advanced Heart Failure: Overview
1) Diagnosis
2) Etiology
3) Approach to management
4) Recent clinical trials and trials in
progress
Heart Failure: Prognosis
1) Individual prognostic markers and
algorithms (SHFS, HFSS, EFFECT)
2) Overview of CPET
Advanced Heart Failure: Treatment
1) Current standard of care for treat-
ment of advanced HF
2) Timing of referral for advanced
therapies (MCSD, Transplant, CRT)
Indications for CRT
1) Evidence-based approach to patient
selection and outcomes with CRT
2) Overview of off-label indications includ-
ing the difficult cases (RBBB, AFib)
End-of-Life Care
1) Framework for assessing issues in
patients with advanced HF nearing
end of life
2) Advanced care directives
4:15 pm BREAK | 4:30 pm
SESSION 2:
Mechanical Circulatory
Support
This session will cover the following
topics via lectures and panel discussion:
Indications for MCS
1) Short-term versus long-term support
2) Bridge to transplant, bridge to
recovery, and destination therapy
3) Left ventricular, right ventricular,
and bi-ventricular support
4) Bridge to transplant and destination
therapy MCS criteria
The Influence of Patient Selection
on Outcomes
1) Identification of co-morbidities
2) INTERMACS Classifications
3) Review of Lietz-Miller Risk Analysis
of destination therapy patients
4) SHFM
5) Importance of prognostic models
6) Correlation of risk factors and
outcomes
Classification of Pumps
1) Centrifugal, pulsatile and axial
2) Percutaneous, implantable and
paracorporeal
3) Review of current FDA approved VADs
Surgical Nuances -
Intra-operative and Early Post-
Operative Management
1) Operative Techniques
2) Use of TEE intra-operatively
3) RV Function
4) Suction Events
5) Ventricular Arrhythmias
6) Pulmonary Hypertension
The Nuts and Bolts of Outpatient
Management
1) Blood pressure assessment and
management
2) Anticoagulation regimens
3) Diagnosis and Management of
GI bleeding
4) Thromboembolic Events
5) Driveline Infections
6) Non-device Related Infections
6:30 pm BREAK
7:00 pm
SESSION 3:
Dinner Session: Pictures Are
Worth A Thousand Words:
Imaging, Biopsies and
Hemodynamics
This session will cover the following
topics via case discussions and use of
an audience response system:
· Advanced Heart Failure
· Cardiac Allograft Vasculopathy
· Antibody Mediated Rejection
· Mechanical Circulatory Support
· Pulmonary Hypertension | Sunday, April 25, 2010
7:00 am
Continental Breakfast
7:30 am
SESSION 4:
Cardiac Transplantation
This session will cover the following
topics via lectures and panel discussion:
1) Heart Transplant Candidacy
2) Immediate Post-Transplant
Care
3) Immunosuppression
4) Cellular and Antibody Mediated
Rejection
5) Cardiac Allograft Vasculopathy
6) Infection/Nephropathy
7) Other Complications
(hypertension, hyperlipidemia,
malignancy, diabetes, etc)
9:30 am BREAK
9:45 am
SESSION 5:
Pulmonary Hypertension
This session will cover the following
topics via lectures and panel discussion:
1) Classification and overview of
pathogenesis
2) Diagnosis and end points for
clinical management
3) Physiology and pathophysiology
of the Right Ventricle
4) Managing the potential heart
transplant recipient with a
raised PVR
5) Treatment of PAH - State of
the Art Overview
11:45 am
CONCLUSION AND
ADJOURN | 
FACULTY AND STEERING
COMMITTEE MEMBERS
CO-CHAIR: James K. Kirklin, MD,
University of Alabama at Birmingham,
Birmingham, AL
CO-CHAIR: Mandeep R. Mehra, MD,
University of Maryland School of
Medicine, Baltimore, MD
Heather J. Ross, MD, FRCPC, Toronto
General Hospital, Toronto, CANADA
James B. Young, MD, Cleveland Clinic
Foundation, Cleveland, OH
John B. O'Connell, MD, St. Joseph's
Hospital, Atlanta, GA
Francis D. Pagani, MD, PhD, University of
Michigan Hospital, Ann Arbor, MI
Andreas O. Zuckermann, MD, University
of Vienna, Vienna, AUSTRIA
Roberta C. Bogaev, MD, FACC, Texas Heart
Institute, Houston, TX
Jayan Parameshwar, FRCP, Papworth
Hospital, Cambridge, UNITED KINGDOM
Jon Kobashigawa, MD, Cedars Sinai
Heart Institute, Los Angeles, CA
Patricia A. Uber, PharmD, University of
Maryland, Baltimore, MD
Paul A. Corris, MB FRCP, Freeman Hospital,
Newcastle Upon Tyne, UNITED KINGDOM
Myung H. Park, MD, University of Maryland
School of Medicine, Baltimore, MD
Allen S. Anderson, MD, University of
Chicago Medical Center, Chicago, IL
Anne I. Dipchand, MD, Hospital for Sick
Children, Toronto, CANADA
James F. George, PhD, University of
Alabama at Birmingham, Birmingham, AL |
